Cyclerion Therapeutics (CYCN) Notes Payables (2020 - 2021)
Cyclerion Therapeutics (CYCN) posted Notes Payables of $3.5 million for Q3 2021, little changed on a QoQ basis from $3.5 million in Q2 2021, and little changed year-over-year from $3.5 million in Q3 2020.
Powered by 
Analysis
Cyclerion Therapeutics (CYCN) Notes Payables (2020 - 2021) Analysis & Trends
Cyclerion Therapeutics has reported Notes Payables for 2 years, with the latest figure at $3.5 million in Q3 2021.
- On a quarterly basis, Notes Payables changed 0.0% year-over-year to $3.5 million in Q3 2021; TTM through Sep 2021 was $3.5 million, a 0.0% change from a year earlier, with the FY2020 full-year figure at $3.5 million, changed N/A from the prior year.
- Notes Payables was $3.5 million for Q3 2021 at Cyclerion Therapeutics, roughly flat from $3.5 million in the prior quarter.
- The five-year high for Notes Payables was $3.5 million in Q2 2020, with the low at $3.5 million in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.70 Bn | 192.71 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.18 Bn | 177.00 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.60 Bn | 55.42 Bn | 1.37 Bn |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.46 Bn | 30.15 Bn | 992.69 Mn |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.10 Bn | 29.10 Bn | 1.16 Mn |
| 10 | Cyclerion Therapeutics | 15.70 Mn | 12.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 3.51 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.51 Mn |
| Dec 31, 2020 | 3.51 Mn |
| Sep 30, 2020 | 3.51 Mn |
| Jun 30, 2020 | 3.51 Mn |